Story thread · 2 reports / 2 sources
CDC warns 40% mortality in arbovirus cases tied to B cell therapies
beckershospitalreview.com · 2h
How the coverage leans
Across 2 sources · syndicated copies counted once
The CDC has issued a Health Alert Network advisory warning of the risk of severe arboviral neuroinvasive disease among patients receiving B cell-depleting or B cell-modulating medications, particularly anti-CD20 monoclonal antibodies. Among published case reports of arboviral neuroinvasive disease in patients taking anti-CD20 monoclonal antibodies, overall mortality was approximately 40%, according to the Aug. 11 […] The post CDC warns 40% mortality in arbovirus cases tied to B cell therapies appeared first on Becker's Hospital Review | Healthcare News & Analysis .
First report: CDC Warns of Severe Arboviral Disease With B-Cell Drugs — medpagetoday.com, 1d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.